RBBP4 downregulation increases the sensitivity of A549 and HeLa cells to cisplatin by inhibiting cyclin D1 expression
This study showed that RBBP4 regulates the sensitivity of tumor cells to cisplatin and is a potential target for reversing cisplatin resistance in tumor cells.
Authors
- Jingjing Zhong
- Zhiyu Zeng (ORCID: https://orcid.org/0000-0002-7383-2700)
- Meiqing Mai
- Jinjun Rao (ORCID: https://orcid.org/0000-0001-7998-2091)
- Zhiru Chen
- Dandan Wang (ORCID: https://orcid.org/0000-0002-9370-0668)
- Jie Ouyang
Institutions
- Jinan University (CN)
- Guangdong Pharmaceutical University (CN)
- Xiyuan Hospital (CN)
- Riverside Hospital of Guangxi Zhuang Autonomous Region (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Clinics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.clinsp.2025.100637
- Citations
- 4
- Primary Topic
- Chemotherapy-induced organ toxicity mitigation
- Type
- article
- Field-Weighted Citation Impact
- 5.89